Medtronic announced today that it entered into a distribution agreement with Merit Medical Systems for its ViaVerte system.

Medtronic (NYSE:MDT) announced the launch of the EMBRACE trial of its Symplicity Spyral renal denervation (RDN) system.

Medtronic said Tuesday that it has struck a distribution agreement for a back pain treatment made by Merit Medical. The ...

Medtronic, a global leader in healthcare technology, has been recognized as one of the 2026 World’s Most Ethical Companies® ...

GALWAY, Ireland, May 7, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full ...

Merit’s ViaVerte nerve ablation system for chronic lower-back pain expands Medtronic’s lineup of chronic pain treatments.

Our acute care and monitoring solutions address unmet clinical needs, reduce the cost of care, 6-9 and streamline workflows, 10-12 all while keeping the patient at the center of everything we do. Our ...

The new system approvals and indications set the stage for significant access across Europe, North America, and Asia — extending the benefits of minimally invasive surgery to new global audiences. As ...

GALWAY, Ireland, Feb. 11, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, February 17, 2026, ...

GALWAY, Ireland, Feb. 13, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth AXiS™ ...

The data in this schedule has been intentionally rounded to the nearest million, and, therefore, may not sum.

Deal demonstrates Medtronic's commitment to expanding pipeline through strategic investments and targeted acquisitions Exercising option to acquire will bolster Medtronic's interventional cardiology ...